质母细胞瘤中的病毒:证据和临床试验的最新情况
Bavani Gunasegaran1, Caroline L Ashley2,3, Felix Marsh-Wakefield2,3,4
1Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW, Australia.
BJC reports
|November 8, 2024
概括
本综述探讨了病毒在质母细胞瘤 (GB) 发展中的有争议的作用. 它总结了目前关于英国病毒存在的证据,以及正在进行的抗病毒疗法的临床试验.
科学领域:
- 神经瘤学神经瘤学
- 病毒学 病毒学
- 癌症研究 癌症研究
背景情况:
- 质母细胞瘤 (GB) 是一种具有不确定的病因的侵袭性脑瘤.
- 病毒与其他癌症有关,这促使人们对它们在GB病原发生中的作用进行调查.
- 病毒对GB的参与仍然是科学文献中一个有争议的话题.
研究的目的:
- 审查关于质母细胞瘤中病毒存在的现有知识.
- 提供针对GB的抗病毒疗法的临床试验的最新信息.
- 确定有关病毒和GB的知识差距.
主要方法:
- 对英国病毒检测研究的综合文献综述.
- 对正在进行和已完成的临床试验进行分析,涉及GB的抗病毒治疗.
- 综合当前的证据,并确定研究的局限性.
主要成果:
- 总结了有关英国存在病毒的证据.
- 介绍了英国抗病毒疗法的当前临床试验环境.
- 突出了需要进一步研究的关键领域.
结论:
- 病毒在质母细胞瘤病因学中的作用需要进一步研究.
- 了解病毒参与可能会导致新的治疗策略.
- 持续的研究对于澄清病毒和GB之间的联系至关重要.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


